Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001716774-26-000011
Filing Date
2026-04-28
Accepted
2026-04-28 09:38:28
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6967
  Complete submission text file 0001716774-26-000011.txt   8813
Mailing Address 1 GEORGE STREET EDINBURGH X0 EH2 2LL
Business Address 1 GEORGE STREET EDINBURGH X0 EH2 2LL 0131 245 2552
Aberdeen Group plc (Filed by) CIK: 0001716774 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003
Business Address 51 ASTOR PLACE, 10TH FLOOR NEW YORK NY 10003 212-284-2300
Perceptive Capital Solutions Corp (Subject) CIK: 0002017526 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-94539 | Film No.: 26903589
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)